 | 4WQ | Name: | (2S)-2-amino-7,7-dimethyloctanoic acid | Formula: | C10 H21 N O2 | SMILES: | NC(C(=O)O)CCCCC(C)(C)C | InChi: | InChI=1S/C10H21NO2/c1-10(2,3)7-5-4-6-8(11)9(12)13/h8H,4-7,11H2,1-3H3,(H,12,13)/t8-/m0/s1 | Definition date: | 2015-06-12 | Last modified: | 2024-09-27 | Release date: | 2015-07-01 | Identifier: | (2S)-2-amino-7,7-dimethyloctanoic acid |
|
 | MAF | Name: | 2-deoxy-2-fluoro-alpha-D-mannopyranose | Formula: | C6 H11 F O5 | SMILES: | FC1C(O)C(O)C(OC1O)CO | InChi: | InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3+,4-,5-,6-/m1/s1 | Synonyms: | 2-DEOXY-2-FLUORO-ALPHA-D-MANNOSE | Definition date: | 2002-02-28 | Last modified: | 2024-09-27 | Identifier: | 2-deoxy-2-fluoro-alpha-D-mannopyranose |
|
 | MAH | Name: | 3-HYDROXY-3-METHYL-GLUTARIC ACID | Formula: | C6 H10 O5 | SMILES: | O=C(O)CC(O)(C)CC(=O)O | InChi: | InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10) | Definition date: | 2000-01-12 | Last modified: | 2024-09-27 | Identifier: | 3-hydroxy-3-methylpentanedioic acid |
|
 | MAN | Name: | alpha-D-mannopyranose | Formula: | C6 H12 O6 | SMILES: | OC1C(O)C(OC(O)C1O)CO | InChi: | InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6+/m1/s1 | Synonyms: | alpha-D-mannose | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | alpha-D-mannopyranose |
|
 | MAO | Name: | 5'-DEOXY-5'-[N-METHYL-N-(2-AMINOOXYETHYL) AMINO]ADENOSINE | Formula: | C13 H21 N7 O4 | SMILES: | n2c1c(ncnc1n(c2)C3OC(C(O)C3O)CN(CCON)C)N | InChi: | InChI=1S/C13H21N7O4/c1-19(2-3-23-15)4-7-9(21)10(22)13(24-7)20-6-18-8-11(14)16-5-17-12(8)20/h5-7,9-10,13,21-22H,2-4,15H2,1H3,(H2,14,16,17)/t7-,9-,10-,13-/m1/s1 | Definition date: | 2001-03-12 | Last modified: | 2024-09-27 | Identifier: | 5'-{[2-(aminooxy)ethyl](methyl)amino}-5'-deoxyadenosine |
|
 | MAY | Name: | METHYL ARACHIDONYL FLUOROPHOSPHONATE | Formula: | C21 H36 F O2 P | SMILES: | FP(=O)(OC)CCCCC=C/CC=C/CC=C/CC=C/CCCCC | InChi: | InChI=1S/C21H36FO2P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(22,23)24-2/h7-8,10-11,13-14,16-17H,3-6,9,12,15,18-21H2,1-2H3/b8-7-,11-10-,14-13-,17-16-/t25-/m0/s1 | Synonyms: | MAFP | Definition date: | 2002-10-01 | Last modified: | 2024-09-27 | Identifier: | methyl (S)-(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-ylphosphonofluoridate |
|
 | MAZ | Name: | FORMIC ACID 3-AMINO-BENZYL ESTER | Formula: | C8 H9 N O3 | SMILES: | O=COCc1cc(N)ccc1 | InChi: | InChI=1S/C8H9NO3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5,9H2,(H,10,11) | Synonyms: | META-AMINO BENZYLOCARBONYL | Definition date: | 2001-09-21 | Last modified: | 2024-09-27 | Identifier: | 3-aminobenzyl formate |
|
 | MB8 | Name: | (2Z)-2-methylbut-2-enoic acid | Formula: | C5 H8 O2 | SMILES: | O=C(O)C(=C/C)C | InChi: | InChI=1S/C5H8O2/c1-3-4(2)5(6)7/h3H,1-2H3,(H,6,7)/b4-3- | Definition date: | 2012-09-21 | Last modified: | 2024-09-27 | Release date: | 2014-05-07 | Identifier: | (2Z)-2-methylbut-2-enoic acid |
|
 | 4XP | Name: | 4,4'-propane-1,3-diylbis(1-methyl-1H-1,2,3-triazole) | Formula: | C9 H14 N6 | SMILES: | C(Cc1nnn(C)c1)Cc2nnn(c2)C | InChi: | InChI=1S/C9H14N6/c1-14-6-8(10-12-14)4-3-5-9-7-15(2)13-11-9/h6-7H,3-5H2,1-2H3 | Definition date: | 2015-06-18 | Last modified: | 2024-09-27 | Release date: | 2016-06-29 | Identifier: | 4,4'-propane-1,3-diylbis(1-methyl-1H-1,2,3-triazole) |
|
 | 4XQ | Name: | 4,4'-pentane-1,5-diylbis(1-propyl-1H-1,2,3-triazole) | Formula: | C15 H26 N6 | SMILES: | C(Cn1cc(nn1)CCCCCc2cn(CCC)nn2)C | InChi: | InChI=1S/C15H26N6/c1-3-10-20-12-14(16-18-20)8-6-5-7-9-15-13-21(11-4-2)19-17-15/h12-13H,3-11H2,1-2H3 | Definition date: | 2015-06-18 | Last modified: | 2024-09-27 | Release date: | 2016-06-29 | Identifier: | 4,4'-pentane-1,5-diylbis(1-propyl-1H-1,2,3-triazole) |
|
 | MBD | Name: | 3-METHYLCATECHOL | Formula: | C7 H8 O2 | SMILES: | Oc1c(cccc1O)C | InChi: | InChI=1S/C7H8O2/c1-5-3-2-4-6(8)7(5)9/h2-4,8-9H,1H3 | Synonyms: | 3-METHYL-BENZENE-1,2-DIOL | Definition date: | 2001-12-19 | Last modified: | 2024-09-27 | Identifier: | 3-methylbenzene-1,2-diol |
|
 | MBQ | Name: | 2-HYDROXY-5-({1-[(4-METHYLPHENOXY)METHYL]-3-OXOPROP-1-ENYL}AMINO)-L-TYROSINE | Formula: | C20 H22 N2 O6 | SMILES: | O=C(O)C(N)Cc2c(O)cc(O)c(NC(=CC=O)COc1ccc(cc1)C)c2 | InChi: | InChI=1S/C20H22N2O6/c1-12-2-4-15(5-3-12)28-11-14(6-7-23)22-17-9-13(8-16(21)20(26)27)18(24)10-19(17)25/h2-7,9-10,16,22,24-25H,8,11,21H2,1H3,(H,26,27)/b14-6+/t16-/m0/s1 | Definition date: | 2004-03-04 | Last modified: | 2024-09-27 | Identifier: | 2-hydroxy-5-({(1E)-1-[(4-methylphenoxy)methyl]-3-oxoprop-1-en-1-yl}amino)-L-tyrosine |
|
 | 4Y8 | Name: | 1-hydroxypropan-2-one | Formula: | C3 H6 O2 | SMILES: | O=C(C)CO | InChi: | InChI=1S/C3H6O2/c1-3(5)2-4/h4H,2H2,1H3 | Definition date: | 2015-03-05 | Last modified: | 2024-09-27 | Release date: | 2015-07-01 | Identifier: | 1-hydroxypropan-2-one |
|
 | V8U | Name: | 3-[5-[(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-yl)methyl]-2-[[5-[(3-ethyl-4-methyl-5-oxidanylidene-pyrrol-2-yl)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1~{H}-pyrrol-2-yl]methyl]-4-methyl-1~{H}-pyrrol-3-yl]propanoic acid | Formula: | C33 H38 N4 O6 | SMILES: | CCC1=C(C)C(=O)N=C1Cc2[nH]c(Cc3[nH]c(CC4=NC(=O)C(=C4C)C=C)c(C)c3CCC(O)=O)c(CCC(O)=O)c2C | InChi: | InChI=1S/C33H38N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h8,34-35H,2,7,9-15H2,1,3-6H3,(H,38,39)(H,40,41) | Definition date: | 2023-02-27 | Last modified: | 2024-09-27 | Release date: | 2024-02-28 | Identifier: | 3-[5-[(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-yl)methyl]-2-[[5-[(3-ethyl-4-methyl-5-oxidanylidene-pyrrol-2-yl)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1~{H}-pyrrol-2-yl]methyl]-4-methyl-1~{H}-pyrrol-3-yl]propanoic acid |
|
 | 4YG | Name: | (1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-[N-(methanesulfonyl)-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C28 H39 N5 O6 S2 | SMILES: | CC(C)C(NS(C)(=O)=O)C(=O)N1CC2C(C1C(=O)NC(CC1CCNC1=O)C(O)c1nc3ccccc3s1)C2(C)C | InChi: | InChI=1S/C28H39N5O6S2/c1-14(2)21(32-41(5,38)39)27(37)33-13-16-20(28(16,3)4)22(33)25(36)30-18(12-15-10-11-29-24(15)35)23(34)26-31-17-8-6-7-9-19(17)40-26/h6-9,14-16,18,20-23,32,34H,10-13H2,1-5H3,(H,29,35)(H,30,36)/t15-,16-,18-,20-,21-,22-,23-/m0/s1 | Definition date: | 2021-07-15 | Last modified: | 2024-09-27 | Release date: | 2021-11-10 | Identifier: | (1R,2S,5S)-N-{(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-3-[N-(methanesulfonyl)-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
 | 4YU | Name: | methyl (2E)-4-{[(5-methoxy-1,2-dimethyl-1H-indol-3-yl)carbonyl]amino}but-2-enoate | Formula: | C17 H20 N2 O4 | SMILES: | O(C)c2ccc1n(c(c(C(NCC=[C@H]C(=O)OC)=O)c1c2)C)C | InChi: | InChI=1S/C17H20N2O4/c1-11-16(17(21)18-9-5-6-15(20)23-4)13-10-12(22-3)7-8-14(13)19(11)2/h5-8,10H,9H2,1-4H3,(H,18,21) | Definition date: | 2015-06-26 | Last modified: | 2024-09-27 | Release date: | 2015-09-30 | Identifier: | methyl (2E)-4-{[(5-methoxy-1,2-dimethyl-1H-indol-3-yl)carbonyl]amino}but-2-enoate |
|
 | V9C | Name: | 2-phenylethylcarbamic acid | Formula: | C9 H11 N O2 | SMILES: | OC(=O)NCCc1ccccc1 | InChi: | InChI=1S/C9H11NO2/c11-9(12)10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7H2,(H,11,12) | Definition date: | 2017-01-09 | Last modified: | 2024-09-27 | Release date: | 2017-11-15 | Identifier: | 2-phenylethylcarbamic acid |
|
 | V9M | Name: | (3R)-N-[(1S)-1-carboxy-2-methylpropyl]-N,3,5,5-tetramethylhexan-1-aminium | Formula: | C15 H32 N O2 | SMILES: | C(C(C(C)C)[NH+](CCC(CC(C)(C)C)C)C)(O)=O | InChi: | InChI=1S/C15H31NO2/c1-11(2)13(14(17)18)16(7)9-8-12(3)10-15(4,5)6/h11-13H,8-10H2,1-7H3,(H,17,18)/p+1/t12-,13-/m0/s1 | Definition date: | 2020-07-21 | Last modified: | 2024-09-27 | Release date: | 2020-09-16 | Identifier: | (3R)-N-[(1S)-1-carboxy-2-methylpropyl]-N,3,5,5-tetramethylhexan-1-aminium |
|
 | VA1 | Name: | {5-[(DIFORMYLAMINO)METHYL]-1-BENZOTHIEN-2-YL}BORONIC ACID | Formula: | C11 H10 B N O4 S | SMILES: | O=CN(C=O)Cc2cc1c(sc(c1)B(O)O)cc2 | InChi: | InChI=1S/C11H10BNO4S/c14-6-13(7-15)5-8-1-2-10-9(3-8)4-11(18-10)12(16)17/h1-4,6-7,16-17H,5H2 | Synonyms: | 5-DIFORMYLAMINOMETHYL-BENZO[B]THIOPHEN-2-BORONIC ACID | Definition date: | 2006-09-01 | Last modified: | 2024-09-27 | Identifier: | {5-[(diformylamino)methyl]-1-benzothiophen-2-yl}boronic acid |
|
 | VAD | Name: | DEAMINOHYDROXYVALINE | Formula: | C5 H10 O3 | SMILES: | O=C(O)C(O)C(C)C | InChi: | InChI=1S/C5H10O3/c1-3(2)4(6)5(7)8/h3-4,6H,1-2H3,(H,7,8)/t4-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-hydroxy-3-methylbutanoic acid |
|
 | VAH | Name: | (3R)-3-hydroxy-L-norvaline | Formula: | C5 H11 N O3 | SMILES: | O=C(O)C(N)C(O)CC | InChi: | InChI=1S/C5H11NO3/c1-2-3(7)4(6)5(8)9/h3-4,7H,2,6H2,1H3,(H,8,9)/t3-,4+/m1/s1 | Synonyms: | L-3-Hydroxynorvaline | Definition date: | 2010-06-16 | Last modified: | 2024-09-27 | Identifier: | (3R)-3-hydroxy-L-norvaline |
|
 | VAI | Name: | (2S)-2-amino-3-methylbutane-1,1-diol | Formula: | C5 H13 N O2 | SMILES: | OC(O)C(N)C(C)C | InChi: | InChI=1S/C5H13NO2/c1-3(2)4(6)5(7)8/h3-5,7-8H,6H2,1-2H3/t4-/m0/s1 | Definition date: | 2011-02-01 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-3-methylbutane-1,1-diol |
|
 | 50A | Name: | 2-deoxy-2-fluoro-5-O-phosphono-alpha-D-ribofuranose | Formula: | C5 H10 F O7 P | SMILES: | FC1C(O)C(OC1O)COP(=O)(O)O | InChi: | InChI=1S/C5H10FO7P/c6-3-4(7)2(13-5(3)8)1-12-14(9,10)11/h2-5,7-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5+/m1/s1 | Synonyms: | Inhibitor CZ-50b arabinosyl-2-fluoro-2-deoxynicotinamide mononucleotide, bound form | Definition date: | 2011-05-24 | Last modified: | 2024-09-27 | Identifier: | 2-deoxy-2-fluoro-5-O-phosphono-alpha-D-ribofuranose |
|
 | VAU | Name: | (1~{R},3~{R},4~{S},5~{R})-3-methyl-1,3,4,5-tetrakis(oxidanyl)cyclohexane-1-carboxylic acid | Formula: | C8 H14 O6 | SMILES: | C[C]1(O)C[C](O)(C[CH](O)[CH]1O)C(O)=O | InChi: | InChI=1S/C8H14O6/c1-7(13)3-8(14,6(11)12)2-4(9)5(7)10/h4-5,9-10,13-14H,2-3H2,1H3,(H,11,12)/t4-,5+,7-,8-/m1/s1 | Definition date: | 2015-03-30 | Last modified: | 2024-09-27 | Release date: | 2015-07-15 | Identifier: | (1~{R},3~{R},4~{S},5~{R})-3-methyl-1,3,4,5-tetrakis(oxidanyl)cyclohexane-1-carboxylic acid |
|
 | VAY | Name: | {(1R,2R,3S,4R)-4-[(5-{4-[(1S)-1-(6-bromopyridin-2-yl)-1-hydroxyethyl]thiophene-2-carbonyl}pyrimidin-4-yl)amino]-2,3-dihydroxycyclopentyl}methyl sulfamate | Formula: | C22 H24 Br N5 O7 S2 | SMILES: | C1C(COS(=O)(N)=O)C(C(C1Nc2c(cncn2)C(c4cc(C(C)(c3cccc(n3)Br)O)cs4)=O)O)O | InChi: | InChI=1S/C22H24BrN5O7S2/c1-22(32,16-3-2-4-17(23)28-16)12-6-15(36-9-12)19(30)13-7-25-10-26-21(13)27-14-5-11(18(29)20(14)31)8-35-37(24,33)34/h2-4,6-7,9-11,14,18,20,29,31-32H,5,8H2,1H3,(H2,24,33,34)(H,25,26,27)/t11-,14-,18-,20+,22+/m1/s1 | Definition date: | 2020-07-22 | Last modified: | 2024-09-27 | Release date: | 2021-03-10 | Identifier: | {(1R,2R,3S,4R)-4-[(5-{4-[(1S)-1-(6-bromopyridin-2-yl)-1-hydroxyethyl]thiophene-2-carbonyl}pyrimidin-4-yl)amino]-2,3-dihydroxycyclopentyl}methyl sulfamate |
|